Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000757760 | SCV000886105 | uncertain significance | not provided | 2018-01-12 | criteria provided, single submitter | clinical testing | The SETX c.5051C>G p.Ser1684Cys variant (rs140116005), to our knowledge, is not reported in the medical literature, gene specific variation databases, nor has it been previously identified by our laboratory. This variant is listed in the genome Aggregation Database (gnomAD) with an overall population frequency of 0.01 % (identified on 38 out of 277,110 chromosomes). The serine at position 1684 is weakly conserved, considering 12 species, and computational analyses of the effects of the p.Ser1684Cys variant on protein structure and function do not agree (SIFT: damaging, MutationTaster: polymorphism, PolyPhen-2: benign). Based on the available information, the clinical significance of the p.Ser1684Cys variant cannot be determined with certainty. |
Athena Diagnostics | RCV000757760 | SCV001145555 | uncertain significance | not provided | 2018-09-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001047649 | SCV001211619 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-10-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000757760 | SCV001747011 | uncertain significance | not provided | 2021-03-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000757760 | SCV001814811 | likely benign | not provided | 2021-05-30 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001849091 | SCV002105165 | uncertain significance | Hereditary spastic paraplegia | 2018-04-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002343608 | SCV002645889 | uncertain significance | Inborn genetic diseases | 2022-06-08 | criteria provided, single submitter | clinical testing | The p.S1684C variant (also known as c.5051C>G), located in coding exon 8 of the SETX gene, results from a C to G substitution at nucleotide position 5051. The serine at codon 1684 is replaced by cysteine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the supporting evidence, this variant is unlikely to be causative of autosomal dominant juvenile amyotrophic lateral sclerosis 4 (ALS4); however, its contribution to the development of autosomal recessive spinocerebellar ataxia with axonal neuropathy 2 (SCAN2) is uncertain. |